$MGHL
MORGAN GROUP HOLDING CO

2022 Q3 Form 10-Q Financial Statement

#000114036122029628 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $413.3K $475.2K $508.8K
YoY Change -12.61% -18.69% -24.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $465.9K $530.0K $553.0K
YoY Change -15.44% -49.82% -42.06%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.740K $2.730K $2.740K
YoY Change -2.14% -2.5% -3.01%
% of Gross Profit
Operating Expenses $602.3K $826.6K $855.9K
YoY Change -26.57% -36.68% -31.0%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$189.0K -$351.3K -$347.1K
YoY Change -45.58% -51.26% -38.28%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$189.0K -$351.3K -$347.1K
YoY Change -45.58% -51.26% -38.28%
Net Earnings / Revenue -45.73% -73.93% -68.22%
Basic Earnings Per Share -$0.31 -$0.59 -$0.58
Diluted Earnings Per Share -$0.31 -$0.59 -$0.58
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K 600.1K
Diluted Shares Outstanding 600.1K 600.1K 600.1K

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.385M $2.500M $2.925M
YoY Change -18.5% -23.93% -25.38%
Cash & Equivalents $2.385M $2.500M $2.925M
Short-Term Investments
Other Short-Term Assets $350.0K $350.0K $350.0K
YoY Change 0.0% 75.0% 75.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.295M $3.334M $3.706M
YoY Change -12.35% -15.39% -19.74%
LONG-TERM ASSETS
Property, Plant & Equipment $14.50K $17.23K $19.97K
YoY Change -43.1% -39.07% -35.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $174.2K $178.1K $148.9K
YoY Change -15.32% -31.36% -35.87%
Total Long-Term Assets $188.7K $195.3K $168.9K
YoY Change -18.38% -32.12% -35.86%
TOTAL ASSETS
Total Short-Term Assets $3.295M $3.334M $3.706M
Total Long-Term Assets $188.7K $195.3K $168.9K
Total Assets $3.484M $3.529M $3.875M
YoY Change -12.7% -16.53% -20.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.288M $936.9K $919.2K
YoY Change 81.95% 49.71% 68.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.335M $984.0K $967.6K
YoY Change 76.9% 46.26% 59.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $207.2K $218.2K
YoY Change -10.25% -4.07%
Total Long-Term Liabilities $0.00 $207.2K $218.2K
YoY Change -100.0% -10.25% -4.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.335M $984.0K $967.6K
Total Long-Term Liabilities $0.00 $207.2K $218.2K
Total Liabilities $1.335M $1.191M $1.186M
YoY Change 31.65% 31.83% 41.87%
SHAREHOLDERS EQUITY
Retained Earnings -$51.74M -$51.55M
YoY Change
Common Stock $6.001K $6.001K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.149M $2.338M $2.689M
YoY Change
Total Liabilities & Shareholders Equity $3.484M $3.529M $3.875M
YoY Change -12.7% -16.53% -20.61%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$189.0K -$351.3K -$347.1K
YoY Change -45.58% -51.26% -38.28%
Depreciation, Depletion And Amortization $2.740K $2.730K $2.740K
YoY Change -2.14% -2.5% -3.01%
Cash From Operating Activities -$115.0K -$424.3K $35.74K
YoY Change -45.24% -32.92% -104.32%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -115.0K -424.3K 35.74K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -115.0K -424.3K 35.74K
YoY Change -45.24% -32.92% -104.32%
FREE CASH FLOW
Cash From Operating Activities -$115.0K -$424.3K $35.74K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
161
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
46
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
936944
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4607305
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-562395
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4044910
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-720895
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3324015
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3036245
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-347113
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2689132
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-351332
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
mghl Number Of Nyse Member Firms Through Which All Securities Transactions Are Cleared
NumberOfNYSEMemberFirmsThroughWhichAllSecuritiesTransactionsAreCleared
3
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
449664
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
566436
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
953403
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1228356
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-351332
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-720895
us-gaap Net Income Loss
NetIncomeLoss
-698445
us-gaap Net Income Loss
NetIncomeLoss
-1283290
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.20
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.14
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
764512
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2337800
us-gaap Net Income Loss
NetIncomeLoss
-698445
us-gaap Net Income Loss
NetIncomeLoss
-1283290
us-gaap Depreciation
Depreciation
5472
us-gaap Depreciation
Depreciation
5630
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
103427
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
48313
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-7061
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2282
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4200
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-501475
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
38589
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-267531
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-224655
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
113
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-29348
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1501
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
172433
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
161293
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
309895
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-176264
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-388550
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1459554
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-388550
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1459554
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3238897
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4946403
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2850347
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3486849
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2500347
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3286849
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
350000
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
200000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2850347
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3486849
mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
-0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
10666
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001140361-22-029628-index-headers.html Edgar Link pending
0001140361-22-029628-index.html Edgar Link pending
0001140361-22-029628.txt Edgar Link pending
0001140361-22-029628-xbrl.zip Edgar Link pending
brhc10040602_10q.htm Edgar Link pending
brhc10040602_ex31-1.htm Edgar Link pending
brhc10040602_ex31-2.htm Edgar Link pending
brhc10040602_ex32-1.htm Edgar Link pending
brhc10040602_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mghl-20220630_cal.xml Edgar Link unprocessable
mghl-20220630_def.xml Edgar Link unprocessable
mghl-20220630_lab.xml Edgar Link unprocessable
mghl-20220630_pre.xml Edgar Link unprocessable
brhc10040602_10q_htm.xml Edgar Link completed